the report called this �one of the most significant perils to humans resulting from human activity.�.
...
.profile.: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".
.
"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened..